A naturally occurring fat molecule reduced heart inflammation and scarring caused by diabetes, thereby improving cardiac function, according to new research. The findings open the door to developing a ...
Please provide your email address to receive an email when new articles are posted on . Beta-blocker use after heart attack in patients with preserved or mildly reduced heart function was assessed in ...
The high-risk angioplasty was performed at Kokilaben Dhirubhai Ambani Hospital, Navi Mumbai, on a patient diagnosed with severe multi-vessel coronary artery disease and a critically low ejection ...
Researchers have reduced scar formation and improved heart function in mouse models of heart failure using a monoclonal antibody treatment, similar to that approved by the FDA to treat other ...
A new analysis, designed to shed light on the benefits of SGLT2 inhibition in patients who have heart failure with preserved ejection fraction (HFpEF), shows that dapagliflozin (Farxiga; AstraZeneca) ...
Hosted on MSN
Beta-blockers recommended for all heart attack patients, even those with no or mild damage
Imagine someone you care about suddenly experiencing chest pain, turning pale, and breathing heavily. These are some of the symptoms of a heart attack. Subscribe to our newsletter for the latest ...
News-Medical.Net on MSN
Study sheds new light on the role of NSUN2 protein in cardiac hypertrophy and heart failure
A recent study published in Engineering has shed new light on the role of the protein NSUN2 in the development of cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results